FDA WARNING_LETTER - Mena Food Group, LLC. - November 20, 2023
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
The FDA inspected a facility in Fort Lauderdale, FL, from October 30 to November 20, 2023, manufacturing ready-to-eat (RTE) bakery products. The inspection revealed serious violations of the Current Good Manufacturing Practice, Hazard Analysis, and Risk-Based Preventive Controls for Human Food regulation (21 CFR Part 117), rendering products adulterated under 21 U.S.C. § 342(a)(4). Additionally, products were found to be misbranded under 21 U.S.C. § 343 due to non-compliance with 21 CFR Part 101 regarding food labeling.
Key violations include: 1. **Hazard Analysis and Risk-Based Preventive Controls (Subpart C):** * Failure to identify and evaluate recontamination with environmental pathogens (e.g., Salmonella, Listeria monocytogenes) as a known or reasonably foreseeable hazard for RTE products, requiring environmental monitoring (21 CFR 117.130(a)(1), 21 CFR 117.135(c)(3), 21 CFR 117.165(a)(3)). * Failure to identify and evaluate mycotoxins (e.g., deoxynivalenol) in high protein wheat flour as a known or reasonably foreseeable hazard, and lack of a risk
ID · f651461e-79fa-4c98-9888-013c74f917f3
Full citation text and observation details available on the Dashboard.